Heart Implant Complication Clinical Trial
Official title:
Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital: 5 Year Experience
| Verified date | February 2020 |
| Source | University Hospital, Basel, Switzerland |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The goal of this study is to demonstrate the challenges and the effort to set up an artificial heart program as well as to report about the follow-up treatment and the mortality rate
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 31, 2019 |
| Est. primary completion date | December 31, 2019 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients who received an LVAD implant Exclusion Criteria: - not enough data collected - stated will of the Patient, that his data can not be used |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | Herzchirurgie University Hospital Basel | Basel |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Basel, Switzerland |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | 30 days mortality | mortality rate 30 days after receiving the LVAD implant | 30 days after surgery | |
| Primary | rehospitalization rate | rehospitalization rate of patients after receiving the LVAD implant | between day of surgery and 31.12.2019 | |
| Secondary | survival rate | survival rate of patients after receiving the LVAD implant (Kaplan-Meier curve) | between day of surgery and 31.12.2019 |